Sign in Register

Trivix (triamcinolone acetonide/dimethicone/silicone, adhesive)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Triamcinolone acetonide is a synthetic fluorinated corticosteroid.

Triamcinolone shares the actions of the other topical corticosteroids and is used for the relief of the inflammatory manifestations of corticosteroid-responsive dermatoses. The drug is also used as a paste for adjunctive treatment to provide temporary relief of symptoms associated with oral inflammatory or ulcerative lesions resulting from trauma.

Generic name: triamcinolone acetonide/dimethicone/silicone, adhesive
Pronunciation: (trye-am-SIN-oh-lone)

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Trivix

Intelligence content is not available yet.

Indications

The following indications are listed for Trivix:

  • Allergic Dermatitis
  • Atopic Dermatitis
  • Contact Dermatitis
  • Discoid Lupus Erythematosus
  • Genital Organ Pruritus
  • Granuloma Annulare
  • Lichen Simplex Chronicus
  • Plaque Psoriasis
  • Pruritus Ani
  • Pruritus Of Skin
  • Pyoderma Gangrenosum
  • Scalp Psoriasis
  • Seborrheic Dermatitis
  • Skin Inflammation

Also known as: Atopic Eczema, Circumscribed Neurodermatitis, Dermatitis, Dermatitis Seborrheica, Dermatitis Venenata, Disseminated Neurodermatitis, Dyssebacea, Dyssebacia, Genital Pruritus, Itchy Skin Eruption, Lichen Annularis, Pruritic Dermatitis, Seborrhea Corporis, Seborrheic Eczema, Unna's Disease, Vidal's Disease.

Dosing

Dermatologic preparations of triamcinolone acetonide are applied sparingly in thin films and are rubbed gently into the affected area 2-4 times daily. The 0.5% cream and 0.5% ointment should be used only in the treatment of dermatoses which are refractory to treatment with lower concentrations. The 0.1 and 0.5% creams are applied 2-3 times daily according to severity of the condition. When the aerosol is applied, an area about the size of the patient's hand is sprayed for about 2 seconds from a distance of about 7.5-15 cm 3 or 4 times daily. Occlusive dressings may be used for severe or resistant dermatoses.

For use in the mouth, a small amount (about 0.6 cm) of the 0.1% paste is pressed to the lesion without rubbing until a thin film develops; a larger amount may be required to cover some lesions. The paste is applied at bedtime and, if necessary, 2 or 3 times daily, preferably after meals. If substantial regeneration or repair of the oral tissues does not occur after 7 days of treatment, further investigation of the etiology of the oral lesions should be undertaken.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

No ICD codes are available for this drug.

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a 5-digit ZIP code. Searching does not change your profile.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data